| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2017 | ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis | Chiu K.-L.; Lin Y.-S.; Kuo T.-T.; Lo C.-C.; Huang Y.-K.; Chang H.-F.; Chuang E.Y.; Lin C.-C.; Cheng W.-C.; Liu Y.-N.; LIANG-CHUAN LAI ; Sher Y.-P.; ERIC YAO-YU CHUANG | Oncotarget | 23 | 24 | |
| 2015 | ADAM9 enhances CDCP1 protein expression by suppressing MIR-218 for lung tumor metastasis | Chiu K.-L.; Kuo T.-T.; Kuok Q.-Y.; Lin Y.-S.; Hua C.-H.; Lin C.-Y.; Su P.-Y.; LIANG-CHUAN LAI ; Sher Y.-P. | Scientific Reports | 26 | 26 | |
| 2014 | ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway | Lin C.-Y.; Chen H.-J.; Huang C.-C.; LIANG-CHUAN LAI ; TZU-PIN LU ; Tseng G.-C.; Kuo T.-T.; Kuok Q.-Y.; Hsu J.L.; Sung S.-Y.; Hung M.-C.; Sher Y.-P. | Cancer Research | 60 | 59 | |
| 2017 | ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT | Lin C.-Y.; Cho C.-F.; Bai S.-T.; Liu J.-P.; Kuo T.-T.; Wang L.-J.; Lin Y.-S.; Lin C.-C.; LIANG-CHUAN LAI ; TZU-PIN LU ; Hsieh C.-Y.; Chu C.-N.; Cheng D.-C.; Sher Y.-P. | Scientific Reports | 29 | 27 | |
| 2014 | ADAM9 up-regulates N-cadherin via miR-218 suppression in lung adenocarcinoma cells | Sher Y.-P.; Wang L.-J.; Chuang L.-L.; Tsai M.-H.; Kuo T.-T.; Huang C.-C.; Chuang E.Y.; LIANG-CHUAN LAI | PLoS ONE | 28 | 29 | |
| 2016 | Aryl Hydrocarbon Receptor Activates NDRG1 Transcription under Hypoxia in Breast Cancer Cells | Li E.-Y.; Huang W.-Y.; Chang Y.-C.; Tsai M.-H.; Chuang E.Y.; Kuok Q.-Y.; Bai S.-T.; Chao L.-Y.; Sher Y.-P.; LIANG-CHUAN LAI | Scientific Reports | 15 | 13 | |
| 2011 | Cancer-targeted BikDD gene therapy elicits protective antitumor immunity against lung cancer | Sher Y.-P.; Liu S.-J.; Chang C.-M.; Lien S.-P.; Chen C.-H.; Han Z.; Li L.-Y.; JIN-SHING CHEN ; Wu C.-W.; Hung M.-C. | Molecular Cancer Therapeutics | 14 | 14 | |
| 1998 | Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients | Peck K.; Sher Y.-P.; JIN-YUAN SHIH ; Roffler S.R.; Wu C.-W.; PAN-CHYR YANG | Cancer Research | 149 | 137 | |
| 2001 | Global analysis of gene expression in invasion by a lung cancer model | Chen J.J.W.; Peck K.; Hong T.-M.; Yang S.-C.; Sher Y.-P.; JIN-YUAN SHIH ; Wu R.; Cheng J.-L.; Roffler S.R.; Wu C.-W.; PAN-CHYR YANG | Cancer Research | 174 | 161 | |
| 2006 | Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness | Sher Y.-P.; Chou C.-C.; Chou R.-H.; Wu H.-M.; Chang W.-S.W.; Chen C.-H.; PAN-CHYR YANG ; Wu C.-W.; CHIA-LI YU ; Peck K. | Cancer Research | 54 | 50 | |
| 2021 | Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma | Cheng W.-C.; Chang C.-Y.; Lo C.-C.; Hsieh C.-Y.; Kuo T.-T.; Tseng G.-C.; Wong S.-C.; Chiang S.-F.; Huang K.C.-Y.; Liang-Chuan Lai ; TZU-PIN LU ; Chao K.S.C.; Sher Y.-P. | Theranostics | 13 | 13 | |
| 2011 | Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genes | Li L.-Y.; Chen H.; Hsieh Y.-H.; Wang Y.-N.; Chu H.-J.; Chen Y.-H.; Chen H.-Y.; Chien P.-J.; Ma H.-T.; Tsai H.-C.; Lai C.-C.; Sher Y.-P.; HUANG-CHUN LIEN ; Tsai C.-H.; Hung M.-C. | Cancer Research | 57 | 51 | |
| 2015 | Potential therapeutic benefit of combining Gefitinib and Tamoxifen for treating advanced lung adenocarcinoma | Liu C.-M.; Chiu K.-L.; Chen T.-S.; Chang S.-M.; Yang S.-Y.; Chen L.-H.; Ni Y.-L.; Sher Y.-P.; SUNG-LIANG YU ; Ma W.-L. | BioMed Research International | 14 | 6 | |
| 2005 | Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes | Sher Y.-P.; JIN-YUAN SHIH ; PAN-CHYR YANG ; Roffler S.R.; Chu Y.-W.; Wu C.-W.; CHIA-LI YU ; Peck K. | Clinical Cancer Research | 102 | 93 | |
| 2020 | Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression | Lin C.-C.; Huang Y.-K.; Cho C.-F.; Lin Y.-S.; Lo C.-C.; Kuo T.-T.; Tseng G.-C.; Cheng W.-C.; Chang W.-C.; Hsiao T.-H.; Liang-Chuan Lai ; JIN-YUAN SHIH ; Liu Y.-H.; Clifford Chao K.S.; Hsu J.L.; Lee P.-C.; Sun X.; Hung M.-C.; Sher Y.-P. | Theranostics | 8 | 9 |
